PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Lana M. Lopes

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

OBESIDADE E ADIPOSIDADE COMO FATORES ASSOCIADOS À DOENÇA HEPÁTICA ESTEATÓTICA ASSOCIADA À DISFUNÇÃO METABÓLICA (MASLD): REVISÃO NARRATIVA DA LITERATURA

Revista Ibero-americana De Humanidades, Ciências E Educação

A narrative literature review synthesizing 43 clinical trials and studies confirming the established association between obesity/adiposity and MASLD, with evidence that weight loss and metabolic improvements reduce hepatic steatosis.

Important Confirmatory EvidenceLana M. Lopes Fernando Menezes Barroso do Bomfim Filho Liver Disease Diagnosis and Treatment

Reported

Studies included in synthesis43

Core studies35

Supporting studies8

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support